MediPal Holdings Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on MediPal Holdings Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting MediPal Holdings Corporation in the form of a SWOT analysis
- An in-depth view of the business model of MediPal Holdings Corporation including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for MediPal Holdings Corporation
- Intelligence on MediPal Holdings Corporationnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about MediPal Holdings Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
MediPal Holdings Corporation (MediPal or ‘the group’) is a Japan-based business group primarily engaged in the wholesale distribution of pharmaceutical products, cosmetics and daily necessities. The group primarily operates in Japan, where it is headquartered in Tokyo. It employed 11,194 people as of March 31, 2012. The group recorded revenues of JPY2,750,233 million ($34,928 million*) during the financial year ended March 2012 (FY2012), an increase of 3.3% over FY2011. The operating profit of the group was JPY20,891 million ($265.3 million*) during FY2012, an increase of 54.2% over FY2011. The net profit was JPY11,651 million ($148 million*) in FY2012, as compared to a net profit of JPY1,705 million ($21.7 million*) in FY2011. *Calculated using a constant conversion rate of JPY1 = $0.0127 during the financial year ended March 31, 2012.
Reasons to Purchase:
- Gain understanding of MediPal Holdings Corporation and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess MediPal Holdings Corporation as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on MediPal Holdings Corporation’s business structure, strategy and prospects
Features:
- Detailed information on MediPal Holdings Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting MediPal Holdings Corporation in the form of a SWOT analysis
- An in-depth view of the business model of MediPal Holdings Corporation including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for MediPal Holdings Corporation
- Intelligence on MediPal Holdings Corporationnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about MediPal Holdings Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
MediPal Holdings Corporation (MediPal or ‘the group’) is a Japan-based business group primarily engaged in the wholesale distribution of pharmaceutical products, cosmetics and daily necessities. The group primarily operates in Japan, where it is headquartered in Tokyo. It employed 11,194 people as of March 31, 2012. The group recorded revenues of JPY2,750,233 million ($34,928 million*) during the financial year ended March 2012 (FY2012), an increase of 3.3% over FY2011. The operating profit of the group was JPY20,891 million ($265.3 million*) during FY2012, an increase of 54.2% over FY2011. The net profit was JPY11,651 million ($148 million*) in FY2012, as compared to a net profit of JPY1,705 million ($21.7 million*) in FY2011. *Calculated using a constant conversion rate of JPY1 = $0.0127 during the financial year ended March 31, 2012.
Reasons to Purchase:
- Gain understanding of MediPal Holdings Corporation and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess MediPal Holdings Corporation as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on MediPal Holdings Corporation’s business structure, strategy and prospects
For more information, please visit:
Or email us at contact@aarkstore.com or call +919272852585
Aarkstore Enterprise
Tel : +912227453309
Mobile No:+08149852585
Email : contact@aarkstore.com
Website : http://www.aarkstore.com
No comments:
Post a Comment